Comparative Response of HCC Cells to TKIs: Modified in vitro Testing and Descriptive Expression Analysis.
Paula SagmeisterJimmy DazaAndrea OfnerAndreas ZieschLiangtao YeNajib Ben KhaledMatthias EbertJulia MayerleAndreas TeufelEnrico N De ToniStefan MunkerPublished in: Journal of hepatocellular carcinoma (2022)
We observed diverse responses to either of the four TKIs. Subgroup analysis of TKI effectiveness showed distinct transcriptomic profiles and signaling pathways associated with responsiveness. This prompts more extensive studies to explore and validate pharmacogenomic and transcriptomic strategies for a personalized treatment approach, particularly after the failure of CPI treatment.